362 related articles for article (PubMed ID: 14586541)
1. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
Jaskiw GE; Bongiovanni R
Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
[TBL] [Abstract][Full Text] [Related]
2. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.
Jaskiw GE; Kirkbride B; Newbould E; Young D; Durkalski V; Bongiovanni R
Psychopharmacology (Berl); 2005 Jun; 179(4):713-24. PubMed ID: 15682305
[TBL] [Abstract][Full Text] [Related]
3. 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release.
Lucas G; Bonhomme N; De Deurwaerdère P; Le Moal M; Spampinato U
Psychopharmacology (Berl); 1997 May; 131(1):57-63. PubMed ID: 9181636
[TBL] [Abstract][Full Text] [Related]
4. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
Osborne PG; O'Connor WT; Beck O; Ungerstedt U
Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ
Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784
[TBL] [Abstract][Full Text] [Related]
6. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
7. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.
Moore H; Todd CL; Grace AA
J Neurosci; 1998 Jul; 18(13):5068-77. PubMed ID: 9634572
[TBL] [Abstract][Full Text] [Related]
8. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
[TBL] [Abstract][Full Text] [Related]
9. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats.
See RE; Chapman MA; Meshul CK
Synapse; 1992 Oct; 12(2):147-54. PubMed ID: 1362290
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion.
Brodnik Z; Double M; Jaskiw GE
Psychopharmacology (Berl); 2013 May; 227(2):363-71. PubMed ID: 23371490
[TBL] [Abstract][Full Text] [Related]
11. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
Invernizzi RW; Garavaglia C; Samanin R
Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
[TBL] [Abstract][Full Text] [Related]
12. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
See RE
Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
[TBL] [Abstract][Full Text] [Related]
13. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
Castelló ME; Bolioli B; Dajas F
Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
[TBL] [Abstract][Full Text] [Related]
14. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
See RE; Murray CE
Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
[TBL] [Abstract][Full Text] [Related]
15. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.
Garris PA; Budygin EA; Phillips PE; Venton BJ; Robinson DL; Bergstrom BP; Rebec GV; Wightman RM
Neuroscience; 2003; 118(3):819-29. PubMed ID: 12710989
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
17. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
Kuczenski R; Schmidt D; Leith N
Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.
Lazzarini M; Salum C; Del Bel EA
Psychopharmacology (Berl); 2005 Aug; 181(1):71-9. PubMed ID: 15806417
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK
Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
